Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Post time 3 day(s) ago

journal：Circulation

Authors：Subodh Verma; C. David Mazer; Andrew T. Yan; Tamique Mason; Vinay Garg; Hwee Teoh; Fei Zuo; Adrian Quan; Michael E. Farkouh; David H. Fitchett; Shaun G. Goodman; Ronald M. Goldenberg; Mohammed Al-Omran; Richard E. Gilbert; Deepak L. Bhatt; Lawrence A. Leiter; Peter Jüni; Bernard Zinman; Kim A. Connelly;

Published date：2019-11-19

DOI：10.1161/circulationaha.119.042375

PDF link：https://www.ahajournals.org/doi/ ... ATIONAHA.119.042375

Article link：https://doi.org/10.1161/circulationaha.119.042375

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AHA] Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AHA] Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AHA] Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease